Trienbio Accelerates Global Expansion at In-Cosmetics Korea 2026

Trienbio, led by CEO Kim Yong-su, announced on the 1st of July that it participated in In-Cosmetics Korea 2026, showcasing its next-generation bio-based cosmetic ingredients alongside proprietary technologies aimed at expanding globally.

The exhibition served as a nexus for domestic and international cosmetic ingredient companies, brands, and research institutions to converge and exchange the latest technological innovations and market trends. Trienbio actively engaged with global buyers, primarily focusing on plant-derived bio-materials and advanced delivery systems, indicating a robust demand for such innovations in the global market.

Significantly, the booth attracted a diverse array of international buyers from Asia, Europe, and North America, who displayed notable interest. These discussions often evolved beyond simple product inquiries into negotiations regarding technical collaborations and joint development initiatives, underscoring the rapid growth of demand for bio-based raw materials on the global stage.

The plant-derived PDRN material captured the most attention at the exhibition, having emerged as a key ingredient for skin regeneration and anti-aging applications. Global companies are increasingly focusing on differentiated ingredients, with some international firms expressing interest in integrating Trienbio's PDRN technology into their product development, illustrating an acknowledgment of Trienbio's competitive technological edge rather than participating merely as suppliers.

Exosomes also maintained a steady interest among global buyers, representing a rapidly growing field of next-generation bio-delivery systems. Discussions centered on the application potential of Trienbio's plant-derived exosome technology extended beyond functional cosmetics into the premium skincare segment, confirming high market expectations for bio-based materials.

Notably, the hybrid oleosome introduced for the first time at the exhibition drew significant attention from attendees. As a relatively unknown material in the market, the frequent inquiries about 'What is oleosome?' highlighted its differentiation from traditional liposomes and exosomes, creating substantial interest among buyers. Trienbio’s near-exclusive presentation of oleosome technology effectively showcased its unique technical capabilities and potential as a new platform.

Through this exhibition, Trienbio reaffirmed that the global market is increasingly gravitating towards scientifically validated bio-materials and unique delivery technologies, extending interest beyond just natural extracts. This trend points to a growing demand for raw materials that are not only functional but also incorporate unique underlying technologies.

A Trienbio spokesperson remarked, "In-Cosmetics Korea was a meaningful opportunity to engage directly with global customers and ascertain the technologies and products the market demands. Going forward, we will continue to develop next-generation bio-materials such as plant-derived PDRN, exosomes, and oleosomes, striving to evolve into a technology-centric company alongside our global partners."